EMV vs PAR

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

EMV

EMVISION FPO [EMV]

49LOW

PAR

PARA BIO FPO [PAR]

49LOW

Score Breakdown

EMV PAR
Technical
57
68
Catalyst
55
67
Sentiment
50
50
Fundamental
70
48
Momentum
54
52
Risk Gate
50
50

Key Metrics

EMV Metric PAR
$145.4MMarket Cap$113.5M
41KAvg Volume (20d)910K
N/AShort Interest+0.4%
$2.43052-Week High$0.480
$1.52552-Week Low$0.240
+1.0%Daily Change+2.8%
$1.580Entry Price$0.257
-58.0%ROE-180.2%
-188.0%Profit MarginN/A

Active Signals

EMV Signals

●RSI drifting toward oversold territory — worth watching
●Trading below both moving averages — the trend is working against this one
●Above-average volume (1.5x) on a green day — buyers stepping up
●Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
●Below the 200-day average — the long-term trend is still working against it
●Adequate cash runway (8 quarters)
●Moderate revenue growth (+11%)
●EPS estimates revised upward (+6pts)

PAR Signals

●RSI drifting toward oversold territory — worth watching
●MACD momentum is picking up steam
●Stochastic just turned bullish from a low level — early reversal sign
●Bollinger Bands are tightening — volatility is coiling up for a potential breakout
●Below the 200-day average — the long-term trend is still working against it
●Low cash runway (2 quarters) - dilution risk
●Very high P/S ratio (13426.2x)
●Strong revenue growth (+51%)

Ask Scout AI to compare EMV and PAR in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
EMV Full Analysis → PAR Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).